Use of animal models in diagnosis and treatment of renal cell carcinoma

1991 ◽  
Vol 9 (4) ◽  
pp. 192-197 ◽  
Author(s):  
R. J. A. van Moorselaar ◽  
J. A. Schalken ◽  
G. O. N. Oosterhof ◽  
F. M. J. Debruyne
Keyword(s):  
Renal Cell Carcinoma ◽  
Animal Models ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Diagnosis And Treatment

scholarly journals The Diagnosis and Treatment of Renal Cell Carcinoma

Cancer ◽  
1980 ◽  
Vol 45 ◽  
pp. 1947-1956 ◽  
Author(s):  
JEAN B. DeKERNION ◽  
DAVID BERRY
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Diagnosis And Treatment

scholarly journals Does Fingolimod have anticancer effects? A meta-analysis and systematic review based on experimental animal models of various cancers

2020 ◽  
Author(s):  
Yuze Ge ◽  
Ping Zhou ◽  
Lu Kong
Keyword(s):  
Renal Cell Carcinoma ◽  
Animal Models ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Meta Analysis ◽  
Signal Pathways ◽  
Bias Analysis ◽  
Immunodeficient Mice ◽  
Anticancer Effects

Abstract Background: Numerous studies have explored the anticancer effect of FTY720 (Fingolimod) in animal models, a sphingosine-1-phosphate (S1P) receptor antagonist and an immunosuppressant, but little clinical evidence guides the use of FTY720 in cancer patients.Methods: Strictly, only related published articles about the treatment with FTY720 for various cancers in vivo from January 1998 to January 2020 were selected from PubMed, Web of Science, Ovid, Embase, CNKI and Cochrane databases, and which were qualified. We acquired agreement through discussion. Then, we conducted meta-analysis, subgroups analysis, publication bias analysis and sensitivity analysis based on selected studies. In the last two sections, we summaried and compared side effects, drug combination effects and molecular pathways from selected studies.Results: In the 31 articles included from 2002 to 2019, FTY720 was found to reduce tumor volume (SMD =-2.58, 95% CI: -3.42, -1.75, Z = 6.09, P = 0.000), tumor weight (SMD = -3.69, 95% CI: -5.17, -2.21, Z = 4.88, P = 0.000) and body weight (SMD = -0.86, 95% CI: -1.61, -0.11, Z = 2.23, P = 0.025) in 14 types of cancer. Relevant frequent signal pathways include the Akt pathway, S1PRs-Caspase pathway and the STAT3-PP2A pathway. FTY720 has significant independent or in combination anticancer effects and a lower toxicity in renal cell carcinoma and neuroblastoma mice models. However, it should be noted that FTY720 achieved a significant therapeutic effect in immunodeficient mice, not in immunecompetent mice. Also, the dosage-safety of FTY720 alone in clinical use is a noteworthy issue. In mouse models, the mechanism of the FTY720 treatment of tumors lies in inducing the tumor cells apoptosis through important signaling moleculars.Conclusions: FTY720 alone or in combination exerted significant anti-tumor effects for neuroblastoma and renal cell carcinoma, however not for melanoma. Due to insufficient evidence, more specific studies of FTY720 only and in combination included in immunity, inflammation and melanoma should be carried out in the future preclinical and clinical studies.

scholarly journals Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC

Neoplasia ◽  
2015 ◽  
Vol 17 (2) ◽  
pp. 215-224 ◽  
Author(s):  
Jeannette C. Oosterwijk-Wakka ◽  
Mirjam C.A. de Weijert ◽  
Gerben M. Franssen ◽  
William P.J. Leenders ◽  
Jeroen A.W.M. van der Laak ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Animal Models ◽  
Cell Carcinoma ◽  
Combination Treatment ◽  
Renal Cell

Advances in the diagnosis and treatment of renal cell carcinoma

2000 ◽  
Vol 5 (5) ◽  
pp. 289-296 ◽  
Author(s):  
Robert O. Northway III ◽  
Chad W.M. Ritenour ◽  
Fray F. Marshall
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Diagnosis And Treatment

Diagnosis and Treatment of Renal Cell Carcinoma in Children: A Report from the Polish Pediatric Rare Tumor Study Group

2011 ◽  
Vol 223 (03) ◽  
pp. 138-141 ◽  
Author(s):  
T. Stachowicz-Stencel ◽  
E. Bien ◽  
A. Balcerska ◽  
J. Godzinski ◽  
A. Synakiewicz ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Diagnosis And Treatment ◽  
Study Group ◽  
Rare Tumor ◽  
Tumor Study ◽  
Tumor Study Group

Landmarks in the diagnosis and treatment of renal cell carcinoma

2014 ◽  
Vol 11 (9) ◽  
pp. 517-525 ◽  
Author(s):  
Jaimin R. Bhatt ◽  
Antonio Finelli
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Diagnosis And Treatment

scholarly journals Research Progress of Renal Cancer

2021 ◽  
Vol 5 (6) ◽  
pp. 34-37
Author(s):  
Ya Liu ◽  
Ping Fan
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cancer ◽  
Renal Cell ◽  
Medical Technology ◽  
Diagnosis And Treatment ◽  
Research Progress ◽  
Urinary System

Renal cell carcinoma (RCC) is one of the most common tumors of the urinary system. With the development of medical technology, the diagnostic rate and incidence of RCC are increasing year by year. This article reviews the latest research progress in the diagnosis and treatment of renal cell carcinoma.

scholarly journals Diagnosis and treatment of cystic renal cell carcinoma

2013 ◽  
Vol 11 (1) ◽  
pp. 158 ◽  
Author(s):  
Jiexiu Zhang ◽  
Bianjiang Liu ◽  
Ninghong Song ◽  
Lixin Hua ◽  
Zengjun Wang ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Diagnosis And Treatment ◽  
Cystic Renal Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document